Influenza Viral Vectors Expressing Two Kinds of HA Proteins as Bivalent Vaccine Against Highly Pathogenic Avian Influenza Viruses of Clade 2.3.4.4 H5 and H7N9.

about

Influenza Viral Vectors Expressing Two Kinds of HA Proteins as Bivalent Vaccine Against Highly Pathogenic Avian Influenza Viruses of Clade 2.3.4.4 H5 and H7N9.

Item

http://www.wikidata.org/entity/Q53829188

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Influenza Viral Vectors Expres ...... of Clade 2.3.4.4 H5 and H7N9.

@en

Influenza Viral Vectors Expres ...... of Clade 2.3.4.4 H5 and H7N9.

@nl

type

Item

label

Influenza Viral Vectors Expres ...... of Clade 2.3.4.4 H5 and H7N9.

@en

Influenza Viral Vectors Expres ...... of Clade 2.3.4.4 H5 and H7N9.

@nl

prefLabel

Influenza Viral Vectors Expres ...... of Clade 2.3.4.4 H5 and H7N9.

@en

Influenza Viral Vectors Expres ...... of Clade 2.3.4.4 H5 and H7N9.

@nl

P1476

Influenza Viral Vectors Expres ...... of Clade 2.3.4.4 H5 and H7N9.

@en

P2093

Cheng Peng

http://www.w3.org/2001/XMLSchema#string

Guangyu Hou

http://www.w3.org/2001/XMLSchema#string

Jinping Li

http://www.w3.org/2001/XMLSchema#string

Suchun Wang

http://www.w3.org/2001/XMLSchema#string

Wenming Jiang

http://www.w3.org/2001/XMLSchema#string

Xiaohui Yu

http://www.w3.org/2001/XMLSchema#string

Yan Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes

High cleavage efficiency of a 2A peptide derived from porcine teschovirus-1 in human cell lines, zebrafish and mice

Vectors based on modified vaccinia Ankara expressing influenza H5N1 hemagglutinin induce substantial cross-clade protective immunity

Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus

A DNA transfection system for generation of influenza A virus from eight plasmids

Continued evolution of H5N1 influenza viruses in wild birds, domestic poultry, and humans in China from 2004 to 2009.

Evaluation of avian influenza virus isolated from ducks as a potential live vaccine candidate against novel H7N9 viruses.

Impact of vaccines and vaccination on global control of avian influenza.

A recombinant vaccine of H5N1 HA1 fused with foldon and human IgG Fc induced complete cross-clade protection against divergent H5N1 viruses.

Recombinant trimeric HA protein immunogenicity of H5N1 avian influenza viruses and their combined use with inactivated or adenovirus vaccines.

P304

604

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FMICB.2018.00604

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29670587

http://www.w3.org/2001/XMLSchema#string

P921

vector-borne disease

P932

5893818

http://www.w3.org/2001/XMLSchema#string